Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?

JACC Cardiovasc Imaging. 2017 Jun;10(6):713-714. doi: 10.1016/j.jcmg.2016.06.003. Epub 2016 Aug 24.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amyloid Neuropathies, Familial / complications
  • Amyloid Neuropathies, Familial / diagnostic imaging*
  • Amyloid Neuropathies, Familial / genetics
  • Amyloid Neuropathies, Familial / physiopathology
  • Asymptomatic Diseases
  • Cardiomyopathies / complications
  • Cardiomyopathies / diagnostic imaging*
  • Cardiomyopathies / genetics
  • Cardiomyopathies / physiopathology
  • Disease Progression
  • Early Diagnosis
  • Female
  • Genetic Predisposition to Disease
  • Heart Failure / diagnostic imaging
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Phenotype
  • Prealbumin / genetics
  • Predictive Value of Tests
  • Radionuclide Imaging / methods*
  • Radiopharmaceuticals / administration & dosage*
  • Technetium Tc 99m Pyrophosphate / administration & dosage*

Substances

  • Prealbumin
  • Radiopharmaceuticals
  • Technetium Tc 99m Pyrophosphate

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related